Avalo Therapeutics Market Cap

Avalo Therapeutics has a market cap or net worth of $106.00 million as of November 22, 2024. Its market cap has increased by 5,199.83% in one year.

Market Cap

106.00M

Enterprise Value

27.43M

1-Year Change

5,199.83%

Ranking

#4010

Market Cap Chart

Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $106.00M, an increase of 207.24%. That is a compound annual growth rate of 13.24%.

Market Cap History

Date	Market Cap	% Change
Nov 19, 2024	114.90M	1,473.97%
Dec 29, 2023	7.30M	-84.60%
Dec 30, 2022	47.40M	-75.17%
Dec 31, 2021	190.90M	-3.49%
Dec 31, 2020	197.80M	-16.79%
Dec 31, 2019	237.70M	80.35%
Dec 31, 2018	131.80M	58.03%
Dec 29, 2017	83.40M	917.07%
Dec 30, 2016	8.20M	-71.63%
Dec 31, 2015	28.90M	-16.23%

View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Journey Medical	112.18M
Coya Therapeutics	108.60M
INmune Bio	107.98M
Inovio Pharmaceuticals	106.23M
Monopar Therapeutics	106.08M
Karyopharm Therapeutics	105.89M
FONAR	105.20M
Akoya Biosciences	104.58M

Market Cap Rankings